News | June 03, 2008

Micro-Computed Tomography Solution Used to Further Drug Development

June 3, 2008 – Acceleware’s AxRecon image reconstruction solution for micro-computed tomography (CT) was adopted by Eli Lilly, in hopes of speeding up image reconstruction times used in the pharmaceutical development process.

Acceleware’s AxRecon works as a turn-key solution with a low cost of operation that fits into the current CT scanner workflow, reportedly generating fully reconstructed, quality images completed hours sooner than before.

Acceleware’s application acceleration platform utilizes the power of NVIDIA Graphic Processing Units (GPUs) to increase the speed of sophisticated computations, saving on power and space while maintaining image quality, according to the company.

Pharmaceutical researchers regularly use CT Scanners in the drug development process to observe the effects of novel drug candidates on anatomy. However, deriving value from CT Scanners for drug development is hampered by slow image reconstruction time due to insufficient computing power. This reduces efficiency as well as the researcher’s ability to maximize the capabilities of advanced imaging equipment. Acceleware’s solution is said to eliminate the computer processing bottleneck in image reconstruction workflow and speed up the evaluation of drug effectiveness.

For more information:

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT) | July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
Sponsored Content | Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
ACR Updates Radiation Oncology and Medical Physics Guidance With ASTRO and AAPM
News | Radiation Dose Management | July 19, 2017
July 19, 2017 — The American College of Radiology (ACR) recently collaborated with professional medical societies to
Sponsored Content | Videos | CT Angiography (CTA) | July 19, 2017
Matthew Budoff, M.D., FACC, professor of medicine, David Geffen School of Medicine at UCLA, endowed chair of preventi
Overlay Init